Ilan Daskal - 21 Jul 2022 Form 4 Insider Report for NATUS MEDICAL INC

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 21 Jul 2022
Net transaction value: -$634,390
SEC form: 4
Accepted by SEC: 21 Jul 2022, 17:14:17 UTC
Prior SEC filing: 17 Jun 2022
Next SEC filing: 06 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ DOUGLAS BALOG by POWER OF ATTORNEY

Key filing fact

Ilan Daskal filed Form 4 for NATUS MEDICAL INC on 21 Jul 2022.

Key facts

This page summarizes Ilan Daskal's Form 4 filing for NATUS MEDICAL INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Jul 2022, 17:14.

Change

Previous filing in this sequence was filed on 17 Jun 2022.
Current net transaction value: -$634,390.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTUS transaction

Common Stock, $0.001 par value per share

Disposed to Issuer

Transaction value: $634,390
Shares: -18,937
Change %: -100%
Price: $33.50
Shares after: 0
Date: 21 Jul 2022
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ilan Daskal is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement").

Footnote F2

Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.